Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
iRay GroupSHSE:688301 -2.07%95 Gross Margin % is 48.97% as of Jun. 2026, which is 4% below its 10-year median of 51.09. GuruFocus rates SHSE:688301 with a GF Score™ of 95/100 and a GF Value™ of ¥109.99 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 804 Medical Devices & Instruments companies, iRay Group ranks worse than 55.72% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. iRay Group's Gross Profit for the
three
months ended in Jun. 2026 was ¥482 Mil. iRay Group's Revenue for the
three
months ended in Jun. 2026 was ¥985 Mil. Therefore, iRay Group's Gross Margin % for the quarter that ended in Jun. 2026 was 48.97%.
The historical rank and industry rank for iRay Group's Gross Margin % or its related term are showing as below:
SHSE:688301'
s Gross Margin % Range Over the Past 10 Years
Min: 45.99 Med: 51.09 Max: 57.34
Current: 48.6
During the past 11 years, the highestGross Margin % of iRay Group was 57.34%. The lowest was 45.99%. And the median was 51.09%.
SHSE:688301's Gross Margin % is ranked worse than 55.72% of 804
companies
in the Medical Devices & Instruments industry
Industry Median: 52.44
vs SHSE:688301: 48.60
iRay Group had a gross margin of 48.97% for the quarter that ended in Jun. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for iRay Group was -1.00% per year.
iRay Group (SHSE:688301) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
iRay Group had a gross margin of 48.97% for the quarter that ended in Jun. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
iRay Group Gross Margin % Related Terms
iRay Group Gross Margin % Historical Data
* Premium members only.
The historical data trend for iRay Group's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SHSE:688301 vs ISRG, BDX, RMD: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, iRay Group's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
iRay Group Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, iRay Group's Gross Margin % distribution charts can be found below:
* The bar in red indicates where iRay Group's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
iRay Group (SHSE:688301) has a Gross Margin % of 48.97% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on iRay Group and its competitors. This is near median its historical median of 51.09. Over the past decade, iRay Group's Gross Margin % has ranged from 45.99 to 57.34. According to the industry distribution chart, iRay Group ranks #448 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 55.7%.
Is iRay Group's Gross Margin % too high?
iRay Group's current Gross Margin % of 48.97% is near median its 10-year median of 51.09. Over the past 10 years, this metric has ranged from a low of 45.99 to a high of 57.34. The Medical Devices & Instruments industry median Gross Margin % is 52.44. iRay Group's value of 48.97% is 6.6% below this industry median. Based on the distribution chart, iRay Group ranks #448 out of 804 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, iRay Group has a GF Score™ of 95/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does iRay Group's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, iRay Group ranks #448 out of 804 companies for Gross Margin %. This places iRay Group in the lower half of its industry. The industry median Gross Margin % is 52.44. iRay Group's value of 48.97% is 6.6% below this benchmark. Historically, iRay Group's own Gross Margin % has ranged from 45.99 to 57.34 over the past decade. While the company's 10-year median is 51.09 vs. the industry median of 52.44, iRay Group has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.44, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. iRay Group's current Gross Margin % of 48.97% is 6.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on iRay Group and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. iRay Group's current Gross Margin % is 48.97%, which is near median its own 10-year median of 51.09. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is iRay Group stock overvalued right now?
Based on GuruFocus' analysis, iRay Group (SHSE:688301) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥109.99, compared to a current price of ¥88.54 — trading 19.5% below its estimated fair value. The current Gross Margin % is 48.97%, which is near median its 10-year median of 51.09 and 6.6% below the Medical Devices & Instruments industry median of 52.44. iRay Group's overall GF Score™ is 95/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For iRay Group (SHSE:688301), the current Gross Margin % is 48.97% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is iRay Group (SHSE:688301) Overvalued in 2026?
Based on GuruFocus' analysis, iRay Group stock appears to be undervalued.
The current stock price of ¥88.54 is trading 19.5% below its estimated GF Value™ of ¥109.99.
GuruFocus considers iRay Group to be Modestly Undervalued.
Key valuation signals for SHSE:688301:
Gross Margin %: 48.97% (near median its 10-year median of 51.09)
GF Value™: ¥109.99 vs. price of ¥88.54 (19.5% below fair value)
Industry Position: 6.6% below the Medical Devices & Instruments median (#448 of 804)
No single metric tells the full story. See the SHSE:688301 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688301 has been successfully added to your 
